Competition
Current Players Could Face Competition in the PCSK9 Space
Nice Insight
PAO-M09-19-NI-010Sep 11, 2019
Clinical Data
New Long-Term Data Show that Twice-a-Year Dosing with Inclisiran Results in Persistent Lowering of LDL Cholesterol
The Medicines Company
PR-M05-19-NI-064May 22, 2019
Drug Pricing
Price Lowered on Cholesterol Drugs
Emilie Branch
Pharma's Almanac
PAO-M02-19-NI-009Feb 12, 2019
Cholesterol
Third PCSK9 Inhibitor for Lowering Cholesterol Moves into Phase III Trials
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M11-18-NI-005Nov 05, 2018